BRITTANY MCPHERSON: Open Payments
NPI 1922401009 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 49 payments from 13 companies in 2025. Trend: 2023 $136 · 2024 $1,126 · 2025 $818
Food & beverage: $818
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $204 |
| Biogen, Inc. | 11 | $138 |
| TG Therapeutics, Inc. | 5 | $138 |
| Alexion Pharmaceuticals, Inc. | 2 | $94 |
| ARGENX US, INC. | 3 | $58 |
| Lundbeck LLC | 2 | $47 |
| GENZYME CORPORATION | 1 | $26 |
| UCB, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Invivyd Inc | 1 | $18 |
Products named: KESIMPTA, BRIUMVI, ULTOMIRIS, VYVGART HYTRULO, VUMERITY, VYEPTI, TYSABRI, Rystiggo.
Industry payments across ND — which companies pay providers there.
